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ABSTRACT
Objectives The purpose of this trial was to
evaluate the efficacy and safety of recently
developed suppositories containing free fatty
acids as a bowel-cleansing agent prior to flexible
sigmoidoscopy and compare them with Klyx
(docusate sodium/sorbitol).
Design A controlled, non-inferiority, single-
blind, randomised study on outpatients
undergoing flexible sigmoidoscopy.
Setting Department of Gastroenterology,
Landspitali-University Hospital and endoscopic
clinic.
Patients 53 outpatients undergoing flexible
sigmoidoscopy.
Intervention Participants were randomised to
receive either free fatty acid suppositories (28) or
a standard bowel preparation with Klyx enema
(25). In the study group, two suppositories were
administered the evening before as well as 2 h
prior to the sigmoidoscopy. In the control group,
Klyx enema (120 mL) was administered the
evening before and repeated 2 h prior to the
procedure.
Main outcome measurements Quality of the
bowel cleansing, height of scope insertion and
safety.
Results The mean height of scope insertion and
bowel cleansing was 43 cm (SD=13.4) in the
study group and 48 cm (SD=10.4) in the control
group (NS). The investigating physicians were less
satisfied with the bowel preparation in the study
group compared with the control group with a
difference of 20% (p<0.016). The amount of
faeces noted in the rectum was similar in both
groups with no significant difference (p<0.56).
No serious side effects, toxic reaction or irritation
were observed.
Conclusions The suppositories are well tolerated
with no significant side effects. The suppositories
had distinct bowel emptying effect and as
effective as Klyx in rectal cleansing. Although
physician’s satisfaction was slightly lower, the
height of scope insertion was similar.
Trial registration number EudraCT nr.:
2010-018761-35.
INTRODUCTION
Flexible sigmoidoscopy is a routine pro-
cedure performed by gastroenterologists
and many surgeons for the diagnosis,
control and treatment of patients with
left-sided colorectal symptoms.1 Bowel
preparation for flexible sigmoidoscopy
should provide a clear view of the intes-
tinal lumen without causing irritation or
inflammation in the mucosa. The visual-
isation of the mucosa must always be the
most important factor especially concern-
ing the evaluation of potential malignant
changes. Non-acceptance of suboptimal
bowel preparation is also required in
order to ensure universally high standards
in screening procedures. The cleansing
should be easy for the patient to adminis-
trate and take effect soon after adminis-
tration.2–4
Several preparations for bowel cleans-
ing for flexible sigmoidoscopy are avail-
able today, and the method of bowel
cleansing varies between countries and
individual clinics.5 The optimal and most
cost-effective bowel-cleansing regimen is
not known.5 Only a few studies have
compared the different bowel-cleansing
methods for flexible sigmoidoscopy.6
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Common methods of bowel cleansing include enemas,
sulfate-free polyethylene glycol electrolyte solution,
bisacodyl, senna, cascara, castor oil, magnesium citrate
and oral sodium phosphate.7 According to the guide-
lines from the American Society for Gastrointestinal
Endoscopy, one or two enemas are recommended as
the bowel preparation of choice for flexible
sigmoidoscopy.7
Recently, suppositories containing free fatty acids
derived from cod liver oil, as the active ingredient,
were studied in a randomised, double-blind, placebo-
controlled clinical trial.8 In this trial, these suppositor-
ies were found to have a clear laxative effect compared
with placebo, where 90% in the study group defecated
compared with 33% in the control group.8 This study
also showed that the suppositories were safe to use
with no significant difference in side effect between
the two groups.8
The purpose of this trial was to evaluate the efficacy
and safety of these recently developed suppositories as
a bowel-cleansing agent prior to flexible sigmoidos-
copy and compare them with Klyx (docusate sodium/
sorbitol), which is the standard preparation used for
cleansing prior to flexible sigmoidoscopy in our
institutions.
METHODS
This was a controlled, non-inferiority, single-blind
randomised prospective clinical trial on outpatients
undergoing flexible sigmoidoscopy in three study
centres. This trial is registered at ClinicalTrials.gov
(EudraCT nr.: 2010-018761-35). This study was
approved by the National Bioethics Committee of
Iceland, the Icelandic Medicines Agency and the Data
Protection Authority.
All patients referred to our institutions for flexible sig-
moidoscopy during the period of November 2010 to
November 2011 were invited to participate in the study.
After a screening visit, all eligible candidates, after
signing an informed consent, were enrolled in the study
and randomised to either the study group or the control
group by block randomisation. The inclusion criteria
included patients with previous history of rectal bleed-
ing, follow-up examination after rectosigmoid surgery
or for polyps. Patients under the age of 18, pregnant
women and patients with diarrhoea or active bleeding
from rectum at the time of the examination as well as all
patients receiving any laxative treatment were excluded.
A total of 53 patients participated in the study. The
number of subjects included and their demographics are
shown in table 1. One of the participants in the Klyx
group did not answer the patient’s questionnaire. The
most common indication for the flexible sigmoidoscopy
was bleeding per rectum (table 1). Patients were rando-
mised to receive either the study suppositories or a
standard treatment with self-administered Klyx enema
(Ferring Pharmaceuticals, Switzerland). In the study
group, the participants self-administered two
suppositories, the evening before, as well as the follow-
ing morning, prior to the flexible sigmoidoscopy. In the
control group, Klyx enema (120 mL) was, in a similar
manner, self-administered the evening before the pro-
cedure, as well as the following morning, prior to the
procedure. Before undertaking the sigmoidoscopy, par-
ticipants filled out a questionnaire about the possible
side effects of the cleansing, that is, if there was any irri-
tation or bleeding, if and when they felt the urge for
defecation, if and when they defecated, as well as if the
smell of the preparations (suppositories and Klyx)
during the treatment was bothering. The investigating
physicians were masked for which bowel cleansing the
participant received and, because of a potential reveal-
ing smell from the suppositories, they wore a surgical
mask containing perfume during the sigmoidoscopy.
The physicians filled out a questionnaire about the
amount of faeces noted in the rectum and sigmoid
colon, any bleeding or mucus, total view, how satisfied
the investigating physicians were with the bowel prepar-
ation, the depth of scope insertion, as well as whether
they felt that the endoscopy should be repeated. The
endoscopists were all experienced and certified specia-
lists in gastroenterology and endoscopy.
Statistical analysis
Statistical tests were performed with the statistical
software R, V.2.15.3. Difference in means was tested
with a Welch two-sample t test. χ2 test for homogen-
eity was used to compare the results for Klyx and the
suppositories for categorical variables. Difference in
medians was tested with Wilcoxon rank sum test. All
reported p values were two-tailed. The level of signifi-
cance was set at 0.05.
RESULTS
After the first application of the suppositories, 12 out
of 28 participants (43%) felt the urge to defecate
within 30 min. Subsequently, 7/28 (25%) had bowel
movements within 30 min. In the group using Klyx,
23/24 (96%) felt the urge to defecate within 30 min.
Subsequently, 22/24 (92%) had bowel movements
Table 1 Demographics and indications for the examinations
Suppositories Klyx
Demographics
Average age (range) 42 (22–83) 40 (23–83)
Gender (men/women) 15/13 8/17
Reason for endoscopy
Rectal bleeding 17 14
Control cancer 1 0
Control operation 1 2
Pruritus ani 2 0
Polyp 0 1
Haemorrhoids 1 0
Other 6 8
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(table 2). The proportion of individuals that felt the
urge to defecate within 30 min was higher for the
group using Klyx (p<0.001) (table 2). The propor-
tion of individuals that had bowel movements within
30 min was higher for the group using Klyx
(p<0.001). After the second application of the sup-
positories, 13/28 (46%) felt the urge to defecate
within 30 min. Subsequently, 11/28 (39%) had bowel
movements within 30 min. In the group using Klyx,
24/24 (100%) felt the urge to defecate. Subsequently,
24/24 (100%) had bowel movements within 30 min.
Five subjects (18%) did not have any bowel movement
after using the suppositories twice, which gives a total
efficacy of 82% in the study group (table 2). The pro-
portion of individuals that felt the urge to defecate
within 30 min was higher for the group using Klyx
(p<0.001). The proportion of individuals that had
bowel movements within 30 min was higher for the
group using Klyx (p<0.001). Complaints of pruritus,
pain or blood per rectum were not significantly differ-
ent in the two groups; however, the smell was signifi-
cantly worse in the study group (data not shown).
The mean depth of scope insertion was 43 cm
(SD=13.4) in the study group and 48 cm (10.4) in
the Klyx group. The difference was non-significant
(figure 1). The amount of faeces noted in the rectum
was similar in both groups with no significant differ-
ence (table 3). However, larger amounts of faeces
were noted in the sigmoid colon in the study group
(table 3). Mucus was noted in 9/28 (32%) subjects in
the study group compared with 15/25 (60%) subjects
in the Klyx group. The amount of blood observed
was similar in both groups (table 3). The overall view
rated by the physicians as good, average or bad was
higher in the Klyx group, although the differences
were small (figure 2). Rated on a scale from 1 to 10,
the investigating physicians were less satisfied with the
bowel preparation in the study group (median 7) com-
pared with the Klyx group (median 9) (figure 3). No
physician felt the need to repeat the endoscopy.
No serious side effects, toxic reaction or irritation
were observed in either group.
DISCUSSION
The suppositories were well tolerated with no signifi-
cant side effects. The suppositories are as good as
Klyx in regards to providing view of the rectum but
Table 2 Time until the urge for bowel movement and time until
bowel movement after administration of suppositories or Klyx
Suppositories Klyx
First
application
Second
application
First
application
Second
application
Time until urge for bowel movement (min)
1–5 1 7 10 12
5–10 4 3 10 11
10–30 7 3 3 1
>30 7 4 1 0
No urge 9 11 0 0
Time until bowel movement (min)
1–5 0 3 4 9
5–10 1 3 13 13
10–30 6 5 5 2
>30 9 7 1 0
No bowel
movement
12 10 1 0
Figure 1 Frequency of depth of scope insertion in centimetre for Klyx (on the left) and suppositories (on the right) (p=0.09).
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were inferior to Klyx in bowel preparation according
to physicians’ satisfaction, giving less total view
because of more faeces in the sigmoid colon.
The investigating physicians were significantly less
satisfied with the bowel preparation in the study
group. However, according to their assessment, there
was not a need to repeat the examination because of
poor bowel preparation. In a recent study, approxi-
mately 8% of examinations had to be repeated
because of poor bowel preparation.1
Studies investigating the optimal form of bowel
preparation for flexible sigmoidoscopy are lacking,9 10
and no gold standard exists.1 3 The only available
guidelines from the American Society for
Gastrointestinal Endoscopy are from 1988.7 The
studies on bowel preparation for flexible sigmoidos-
copy so far have compared many types of bowel pre-
parations, both different types of enemas, enemas vs.
per oral preparations, combination of per oral treat-
ment and enemas, as well as suppositories vs. enemas.
Most studies have a focus on the quality of the prepar-
ation concerning the endoscopic view6 5 9–14 while
others focus on the variability in adenoma detection
rates.2 9 Although enemas seem to be the preferred by
most physicians,9 there are several options in bowel
preparation for patients undergoing flexible sigmoid-
oscopy, both regarding type of medication and admin-
istration route and the timing of the administration.
Oral preparations have, in some studies, shown to be
superior to enemas,6 9 10 whereas other studies have
found enemas to be superior to oral preparations.11 12
However, other researchers have not found any differ-
ences between enemas and oral preparations.13 14 Few
studies have compared suppositories with other form
of cleansing, thus making it somewhat difficult to
compare our results with the results of previous
studies. Underwood et al conducted a study on 203
patients undertaking flexible sigmoidoscopy who were
randomised to receive one Fleet ready-to-use enema
(sodium dihydrogen phosphate dihydrate, disodium
Table 3 The amount of faeces noted in the sigmoid colon and
rectum as well as the amount of blood and mucus noted during
the endoscopy
Suppositories
No. of
subjects (%)
Klyx
No. of
subjects (%) p Value
Faeces in rectum
No faeces 13 (46) 15 (60) 0.56
Only clear fluid 6 (21) 5 (20)
Liquid faeces 3 (11) 3 (12)
>90% of mucosa visible 6 (21) 1 (4)
<90% of mucosa visible 0 (0) 1 (4)
Faeces in the sigmoid colon
No faeces 11 (39) 17 (68) 0.02
Small amount 8 (29) 7 (28)
Large amount 9 (32) 1 (4)
Amount of blood noted
No blood 26 (96) 25 (100) NS
Small amount of blood 1 (4) 0 (0)
Large amount of blood 0 (0) 0 (0)
Amount of mucus noted
No mucus 18 (67) 10 (40) NS
Small amount of mucus 9 (33) 15 (60)
Large amount of mucus 0 (0) 0 (0)
Figure 2 The overall endoscopic view as rated by the physician (p=0.054).
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phosphate dodecahydrate) or 2×4 g glycerin supposi-
tories 2 h prior to the procedure. They found that the
average depth of endoscope insertion in the enema
group was significantly deeper compared with the
group receiving suppositories. Moreover, the physi-
cians grated the quality of preparation as excellent in
67% among the patients in the enema group as com-
pared with only 17% in the glycerin group.15 These
results are in line with our findings, although the dif-
ference between the suppositories and enema was less
evident in our study.
The quality of bowel preparation scale (excellent,
good, adequate or poor) derived from the Walter Reed
Army Medical Center10 or the assessment used in the
United Kingdom flexible sigmoidoscopy trial (UKFSST)
study16 do not distinguish between the amount of faeces
in the rectum and in the sigmoid. It is important to note
this difference as cleansing for flexible sigmoidoscopy
should provide the same view in the sigmoid colon as in
the rectum. In this study, the amount of faeces noted in
the sigmoid colon was significantly higher in the study
group, but the amount of faeces in the rectum was small
and similar in both groups.
Although the bowel preparation for the flexible sig-
moidoscopy was better with Klyx, it is possible that
the suppositories are more appropriate as preparation
for proctoscopies. This as well as the effect of dose
escalation remains to be studied.
CONCLUSION
The suppositories were well tolerated with no signifi-
cant side effects. The suppositories are as good as
Klyx in regards to providing view of the rectum. The
optimal use of these suppositories could be for
patients undergoing proctoscopy and to initiate rectal
evacuation when needed. The laxative effect of the
suppositories is confirmed, as is their safety.
Significance of this study
What is already known about this subject?
▸ The newly developed study suppositories were shown
to lead to rectal evacuation in previous trial.
▸ There are few clinical trials published on bowel prep-
aration with suppositories and the role of suppositor-
ies in bowel cleansing is not fully investigated.
▸ The optimal and most cost-effective bowel cleansing
regimen is not known.
What are the new findings?
▸ The suppositories are well tolerated with no signifi-
cant side effects.
▸ The suppositories had bowel emptying effect.
▸ The suppositories were not inferior to Klyx in terms
of depth of scope insertion and rectal cleansing.
How might it impact on clinical practice in the fore-
seeable future?
▸ Suppositories for bowel cleansing could have greater
role in the future.
▸ The optimal use of the study suppositories could be
in the preparation of patients undergoing rectoscopy
and to initiate rectal evacuation when needed.
Figure 3 Physicians’ satisfaction with bowel cleansing (p≤0.016).
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